Treatment of refractory subacute cutaneous lupus erythematosus with baricitinib

Clin Exp Dermatol. 2021. Epub ahead of print

Four months of baricitinib treatment resulted in rapid improvement of skin manifestations in a 54-year-old male with subacute cutaneous lupus erythematosus.


LinkedIn